Recruitment of patients who have had pulmonary tuberculosis into a clinical trial of the GamTBVac vaccine has begun to evaluate the effectiveness of the vaccine in preventing relapse. Remuneration for participation in the study is possible. Write to us 8 (993) 202 7840 (whatsapp).
Our partners
